Advertisement

Streptococcus Suis Infections In Pigs: Prevention And Treatment

Comprehensive guide to understanding, preventing, and treating Streptococcus suis and related infections in swine production.

By Medha deb
Created on

Streptococcal infections pose a major challenge in swine production, particularly affecting young pigs and leading to significant economic losses through mortality and reduced growth. Among these, Streptococcus suis stands out as the primary culprit, causing conditions like meningitis, septicemia, and arthritis, especially in post-weaning stages.

Understanding the Pathogens Involved

Swine are susceptible to several streptococcal species, but Streptococcus suis dominates as the most prevalent and virulent agent. This gram-positive bacterium thrives in the upper respiratory tract and tonsils of carrier pigs, remaining asymptomatic until stress or co-infections trigger disease. Other notable species include Streptococcus dysgalactiae equisimilis, linked to lesions and polyserositis, and Streptococcus porcinus, associated with lymphadenitis in growing pigs. Emerging strains like Streptococcus equi zooepidemicus ST194 have caused high-mortality outbreaks across regions.

These bacteria are alpha- or beta-hemolytic streptococci, classified by their serotypes. Serotype 2 of S. suis is most common in clinical cases, but multiple serotypes can coexist in herds, complicating control efforts.

Epidemiology and Risk Factors in Swine Herds

Infections primarily strike pigs between 3 and 12 weeks old, peaking right after weaning when mixing occurs and maternal antibodies wane. Outbreaks affect 1-5% of weaners if untreated, but carrier rates in breeding stock can persist for over a year in tonsils. Transmission happens via respiratory droplets, nose-to-nose contact, or during farrowing from sows to piglets.

Key risk factors include:

  • Intensive indoor housing with poor ventilation and overcrowding.
  • Co-infections with PRRS virus, Mycoplasma hyorhinis, or Bordetella bronchiseptica, which suppress immunity and enhance S. suis virulence.
  • Mixing pigs from different litters, increasing exposure to virulent strains.
  • Stress from transport, temperature fluctuations, or inadequate nutrition.

PRRS outbreaks notably precede S. suis surges, as the virus impairs macrophage function, allowing bacterial invasion. Even PRRS-free herds face risks, underscoring the pathogen’s ubiquity.

Clinical Manifestations and Disease Progression

Disease onset varies from peracute sudden deaths to chronic polysystemic illness. In weaned pigs, neurological signs dominate, with pigs showing paddling, convulsions, nystagmus, and opisthotonos before coma and death. Septicemic forms present with fever, depression, and hemorrhages, while survivors may develop arthritis (lameness, swollen joints) or polyserositis (fibrinous inflammation on heart, liver, peritoneum).

Less common signs include endocarditis, pneumonia, and bronchopneumonia. Adult pigs rarely show clinical disease but serve as reservoirs. Early detection is crucial, as delays lead to 100% mortality in acute meningitis cases without intervention.

Disease FormKey SignsAffected Age Group
MeningitisConvulsions, head pressing, circlingPost-weaning (3-5 weeks)
SepticemiaFever, lethargy, sudden deathWeaners and growers
Arthritis/PolyarthritisLameness, joint swellingSurvivors of acute cases
PolyserositisLabored breathing, pericarditisNursery pigs

Pathology and Gross Lesions

Necropsy reveals non-specific but suggestive findings: fibrinopurulent meningitis, purulent arthritis, fibrinous pleuritis/pericarditis, and splenomegaly in septicemic cases. Lungs may show bronchopneumonia, and joints contain creamy exudate. These lesions aid presumptive diagnosis but require bacterial culture for confirmation.

Laboratory Diagnosis Techniques

Definitive diagnosis hinges on isolating the bacterium from brain, joints, lungs, spleen, or cerebrospinal fluid of fresh carcasses. Culture on blood agar shows alpha-hemolysis, followed by serotyping and antimicrobial susceptibility testing. PCR assays detect S. suis DNA rapidly, identifying virulence factors like capsular genes.

Histopathology confirms bacterial presence via Gram stains, while ruling out differentials like Glasser’s disease (Haemophilus parasuis) or mycoplasmosis. Herd profiling via tonsil swabs assesses carrier status, though no test distinguishes virulent from commensal strains reliably.

Treatment Protocols for Affected Pigs

Immediate intervention saves lives. Inject affected piglets with penicillin or ampicillin at high doses (e.g., 20,000 IU/kg procaine penicillin twice daily). Supportive care includes isolation, fluids, anti-inflammatories for pain, and nursing. Tetracyclines often fail due to resistance; always base therapy on susceptibility results.

For outbreaks, treat the group via injection or water medication with beta-lactams. Early treatment (within hours of signs) yields full recovery rates over 80%. Avoid over-reliance on antibiotics to curb resistance.

Prevention and Control Strategies

Control integrates management, biosecurity, and targeted interventions:

  • Management Optimization: Minimize mixing, ensure uniform litters, improve ventilation, and reduce density. All-in-all-out systems limit spread.
  • Strategic Medication: Medicate sows pre-farrowing and piglets’ feed early, though this doesn’t eradicate carriers.
  • Vaccination: Autogenous bacterins using herd-specific serotypes offer partial protection; commercial type 2 vaccines help but may fail against others.
  • Sow Management: Screen gilts for carriers; early weaning with medicated rearing in isolation pens.
  • Eradication Attempts: Depopulation-repopulation with monitored stock, though S. suis recolonizes quickly via farrowing.

Addressing co-factors like PRRS vaccination enhances resilience.

Zoonotic Potential and Public Health Concerns

S. suis infects humans, especially abattoir workers and consumers of undercooked pork, causing meningitis, arthritis, or toxic shock. Serotype 2 predominates in zoonoses. Pig handlers should use PPE and cook meat thoroughly.

Economic Impact on Swine Industry

Annual global losses exceed millions from mortality (up to 20% in nurseries), culls, treatments, and growth setbacks. In intensive systems, S. suis rivals PRRS as a top killer.

Future Directions in Research and Management

Ongoing studies focus on virulence genomics, alternative antimicrobials (e.g., bacteriophages), and multivalent vaccines. Precision farming with AI monitoring for early signs promises better outcomes. Antibiotic stewardship is critical amid resistance rises.

Frequently Asked Questions (FAQs)

What is the most common age for S. suis outbreaks?

Primarily 3-12 weeks, especially post-weaning when pigs mix.

Can S. suis be eradicated from a herd?

No, as it’s a tonsillar commensal; control focuses on reducing clinical disease.

What antibiotics work best?

Penicillin and ampicillin; test for susceptibility.

Does vaccination prevent all cases?

No, protection is serotype-specific and partial; autogenous vaccines are preferable.

Is S. suis dangerous to humans?

Yes, via occupational exposure; use precautions.

References

  1. Streptococcus suis Disease in Pigs — The Pig Site. 2023. https://www.thepigsite.com/articles/streptococcus-suis-disease-in-pigs
  2. Streptococcus suis, an important pig pathogen and emerging … – PMC — National Center for Biotechnology Information. 2014-06-17. https://pmc.ncbi.nlm.nih.gov/articles/PMC4078792/
  3. Streptococcus Suis Infection — Pipestone Veterinary Services. 2023. https://pipevet.com/streptococcus-suis-infection
  4. Streptococcal Infections in Pigs – Generalized Conditions — Merck Veterinary Manual. 2023. https://www.merckvetmanual.com/generalized-conditions/streptococcal-infections-in-pigs/streptococcal-infections-in-pigs
  5. Streptococcal Infections – Pig Diseases — Farm Health Online. 2023. https://www.farmhealthonline.com/US/disease-management/pig-diseases/streptococcus-suis/
  6. Streptococcus suis – The “Two Faces” of a Pathobiont in the Porcine … — Frontiers in Microbiology. 2018-03-14. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2018.00480/full
Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb